A real-world study on persistence with ofatumumab in Canadian patients with multiple sclerosis
This study provides insights into real-world ofatumumab utilization among patients with multiple sclerosis and demonstrates that persistence with ofatumumab remained high over 3 years. These results complement data from controlled clinical trials and suggest that patients persist with ofatumumab.
Authors
- Jock Murray
- Rebecca Grant
- Daniel Selchen
- Calum S Neish
- Claire Magnussen
Institutions
- St. Michael's Hospital (CA)
- IQVIA (United Kingdom) (GB)
- IQ Solutions (US)
- Novartis (Canada) (CA)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1016/j.msard.2026.106976
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00